A Stratified, Randomized, Double-blind, Placebo-controlled, Parallel-group, 12 Week Trial Evaluating the Safety and Efficacy of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg Once Daily Versus Fluticasone Propionate DISKUS 100mcg Once Daily and Placebo in Symptomatic Pediatric Subjects (4-11 Years) With Asthma

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2003
This article has no abstract
Epistemonikos ID: 27f97051d5bc64d13f5fa310ee82d38967abe289
First added on: Apr 16, 2025